MedImmune's swelling product pipeline
MedImmune's swelling product pipeline MedImmune Inc. 's decision to buy Melville Biologics, which develops, manufactures and distributes blood-derived products, provides MEDI with an in-house manufactuing facility and could give MEDI up to seven products within two to three years.
"MedImmune's sales reps could end up with seven files in their briefcases instead of two," said Hambrecht & Quist analyst Timothy Wilson. "It will give its sales force an opportunity to sell more products."
Bear Stearns analyst Joseph Ricardo agreed: "By 1995 MedImmune could have 5